Govt must Implement National Agricultural Biotechnology policy : Crop Life Pakistan demands

ISLAMABAD, June 29 (EPI): Executive Director CropLife Pakistan, Rashid Ahmed expressed sincere appreciation to the Prime Minister and the Federal Cabinet for approving Pakistan’s first National Agricultural Biotechnology Policy and National Seed Policy 2026.

He said these important decisions demonstrate the Government’s commitment to improving food security, increasing agricultural productivity, supporting farmers, encouraging innovation, and strengthening Pakistan’s seed and biotechnology sector.

The approval of these policies in April 2026 is an important milestone for Pakistan’s agriculture sector. Developed after nearly two years of rigorous, inclusive consultation— including over 30 sessions with government ministries, regulatory bodies, scientists, provincial representatives, private sector stakeholders, and other key partners—the National Agricultural Biotechnology Policy provides Pakistan a clear path to responsible adoption of modern agricultural technologies including biotechnology, improved seed systems, and research-based innovation.

Rashid Ahmed expressed concern over recent misleading claims in the media and requested all stakeholders to rely on verified data and factual evidence as opposed to unsubstantiated claims.

He expressly rejected inaccurate claims regarding biosafety work on GM maize. Some CropLife member companies were granted licenses to begin GM maize trials in 2009, following which multi-year trials for insect protection and herbicide tolerance were conducted in different regions with approvals from the Technical Advisory Committee and the National Biosafety Committee under the Pakistan Biosafety Rules and Guidelines 2005.

All statutory requirements were fulfilled, and the trial data was reviewed by the Field Monitoring Committee, TAC, TAC Subcommittee, and NBC. Following this, companies were granted commercialization approval in 2016/17. However, due to the absence of a comprehensive biotechnology policy being in place at the time, these commercialization licenses expired after the standard three-year period – they were not suspended, nor cancelled on the basis of any safety concerns, as is currently being incorrectly framed in the media.

The approval of the National Agricultural Biotechnology Policy now provides a clear basis to move forward with GM crop commercialization, including yellow maize as an immediate-release crop.

Another claim being made incorrectly is that China has not adopted GM maize. He clarified that China is proceeding through a regulated and phased GM maize approval process. China’s Ministry of Agriculture and Rural Affairs has granted biosafety certificates, variety registrations, and seed production and operation licenses for several GM maize and soybean varieties.

These approvals include varieties and technologies developed by leading companies of China which developed the maize trait for glyphosate tolerance and resistance to selected insect pests.

Rashid Ahmed also clarified that India has not rejected GM maize technology. India’s Genetic Engineering Appraisal Committee has allowed MNC to conduct confined field trials of selected GM maize events that provide herbicide tolerance and insect resistance. He added that Pakistan started regulatory trials for GM maize in 2009, when only the Philippines had adopted GM maize in Asia.

Unfortunately, in the years since, countries such as China, Indonesia and Vietnam have also moved forward, while Pakistan is still waiting to commercialize the technology.
Responding to concerns about contamination risk, Mr. Rashid said that the majority of maize grain in Pakistan is used by the poultry and animal feed industries; these industries already utilize imported GM soybean and GM canola as feed ingredients. Therefore, far from posing any new risk, GM maize grain production would enter a feed market that is already familiar with, and reliant on, GM products.

He added that maize seed producers in Pakistan already follow isolation-distance and quality-control protocols to maintain seed purity, and similar stewardship measures can be applied for the responsible adoption of GM maize hybrids.

Pakistan earns around USD 350–400 million from maize exports, including grain, forage, and fodder. This export value can increase if farmers adopt better maize technologies, including GM maize hybrids, that can improve crop quality and production. Referring to local wet millers role in maize exports, he said they contribute only about less than 9% of Pakistan’s total maize exports, while the remaining export share comes from other market players.

He also discussed about a common myth regarding EU as Non-GM, which is totally misleading, EU is the second largest importer of GM grain for Food Feed and Processing.
Years of uncertainty, driven by misinformation and vested interests, have weakened confidence in Pakistan’s policies and regulatory system.

Technology developers cannot keep waiting indefinitely. If GM maize commercialization licenses are not renewed now, Pakistan will fall further behind in agricultural innovation, investment will move elsewhere, and the real losers will be Pakistan’s farmers—deprived of urgently-needed technology that can improve productivity, income, and livelihoods.